Clinical Trial Update: Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating prevention of doxorubicin-induced cardiotoxicity in breast cancer patients; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: British University In Egypt | Conditions: Breast Cancer Female | Phase 2 | Status: COMPLETED